Previous close | 1.7500 |
Open | 1.7500 |
Bid | 1.3200 |
Ask | 2.3100 |
Strike | 135.00 |
Expiry date | 2025-06-20 |
Day's range | 1.7500 - 1.7500 |
Contract range | N/A |
Volume | |
Open interest | 1.41k |
AbbVie(NYSE:ABBV) is navigating a period of significant developments, including a robust 4% increase in operational sales and strategic acquisitions to bolster its pipeline. However, challenges such as declining profit margins and competitive pressures persist. In the discussion that follows, we will explore AbbVie's core strengths, critical weaknesses, growth opportunities, and key threats to provide a comprehensive overview of the company's current business situation.
Key Insights Institutions' substantial holdings in AbbVie implies that they have significant influence over the...
AbbVie (ABBV) closed at $193.45 in the latest trading session, marking a -1.16% move from the prior day.